Lab Information

Chen Liang (PhD)

Associate Investigator
Centre for Translational Biology
Department of Medicine (McGill)

Research Profile

 Fundamental: 100%
 Clinical: 0%
 Epidemiology: 0%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

HIV • COVID-19 • SARS-CoV • innate immunity • interferon • antivirals

Research Interests

My research aims to understand the host innate immune responses to viral infections. My team uses the findings to understand viral pathogenesis and transmission and to guide the development of effective antiviral therapeutics. Specifically, we investigate how host cells produce antiviral interferons in response to infections by HIV or SARS-CoV-2, and how these two highly pathogenic viruses overcome and evade this first line of host defense. We are dedicated to the discovery of new HIV treatments and the compounds that can effectively inhibit SARS-CoV-2 and thus cure COVID-19. My lab has also pioneered the application of the CRISPR gene editing tool in curing HIV infection.


Team Members

Name Position

Latest Publications

  1. Laprise, F., Arduini, A., Duguay, M., Pan, Q. & Liang, C. (2024). SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR. Viruses, vol. 16.
  2. Guizar, P., Abdalla, A. L., Monette, A., Davis, K., Caballero, R. E., Niu, M., Liu, X., Ajibola, O., Murooka, T. T., Liang, C. & Mouland, A. J. (2024). An HIV-1 CRISPR-Cas9 membrane trafficking screen reveals a role for PICALM intersecting endolysosomes and immunity. iScience, vol. 27, p. 110131.
  3. Wang, J., Luo, Y., Katiyar, H., Liang, C. & Liu, Q. (2024). The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies. Viruses, vol. 16.
  4. Fan, Z., Xie, Y., Huang, B., Zhao, F., Hu, Y., Huang, Y., Mei, S., Wei, L., Wang, L., Wang, L., Gao, Z., Ai, B., Fang, J., Liang, C., Xu, F., Tan, W. & Guo, F. (2024). Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections. Journal of virological methods, p. 114957.
  5. Hamidi, S. V., Jahromi, A. K., Hosseini, I. I., Moakhar, R. S., Collazos, C., Pan, Q., Liang, C. & Mahshid, S. (2024). Surface-Based Multimeric Aptamer Generation and Bio-Functionalization for Electrochemical Biosensing Applications. Angewandte Chemie (International ed. in English), p. e202402808.
  6. Wang, L., Zhou, R., Liu, Y., Guo, S., Yi, D., Zhao, J., Li, Q., Zhang, Y., Liang, C., Wang, J., Shan, G. & Cen, S. (2023). A cell-based assay to discover inhibitors of Zika virus RNA-dependent RNA polymerase. Virology, vol. 589, p. 109939.
  7. Zhao, F., Hu, Y., Fan, Z., Huang, B., Wei, L., Xie, Y., Huang, Y., Mei, S., Wang, L., Wang, L., Ai, B., Fang, J., Liang, C., Xu, F., Tan, W. & Guo, F. (2023). Rapid and sensitive one-tube detection of mpox virus using RPA-coupled CRISPR-Cas12 assay. Cell reports methods, p. 100620.
  8. Ding, J., Wang, S., Liu, Q., Duan, Y., Cheng, T., Ye, Z., Cui, Z., Zhang, A., Liu, Q., Zhang, Z., Zhang, N., Liu, Q., An, N., Zhao, J., Yi, D., Li, Q., Wang, J., Zhang, Y., Ma, L., Guo, S., Wang, J., Liang, C., Zhou, J., Cen, S. & Li, X. (2023). Schlafen-5 inhibits LINE-1 retrotransposition. iScience, vol. 26, p. 107968.
  9. Liu, Q., Yi, D., Ding, J., Mao, Y., Wang, S., Ma, L., Li, Q., Wang, J., Zhang, Y., Zhao, J., Guo, S., Liu, Z., Guo, F., Zhao, D., Liang, C., Li, X., Peng, X. & Cen, S. (2023). MOV10 recruits DCP2 to decap human LINE-1 RNA by forming large cytoplasmic granules with phase separation properties. EMBO reports, p. e56512.
  10. Wang, Z., Pan, Q., Ma, L., Zhao, J., McIntosh, F., Liu, Z., Ding, S., Lin, R., Chen, S., Finzi, A. & Liang, C. (2023). Anthracyclines inhibit SARS-CoV-2 infection. Virus research, p. 199164.
More on PubMed 



See also

Card image
Silvia
Vidal


See profile